107 related articles for article (PubMed ID: 26117290)
1. Association of Pre-Transplant Angiopoietin-2 Index with the Risk of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation.
Satırer Ö; Cevher Zeytin İ; Alkan B; Karakaya J; Çetinkaya D; Visal Okur F
Turk J Haematol; 2022 Feb; 39(1):61-65. PubMed ID: 34617432
[TBL] [Abstract][Full Text] [Related]
2. Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.
Kuba A; Raida L
Mediators Inflamm; 2018; 2018():9451950. PubMed ID: 29785172
[TBL] [Abstract][Full Text] [Related]
3. Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease.
Crossland RE; Norden J; Kralj Juric M; Pearce KF; Lendrem C; Bibby LA; Collin M; Greinix HT; Dickinson AM
Front Immunol; 2017; 8():1446. PubMed ID: 29176973
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.
Fattahi F; Ward PA
Transl Res; 2016 Jan; 167(1):1-6. PubMed ID: 26323016
[TBL] [Abstract][Full Text] [Related]
5. Acute Graft
Nassereddine S; Rafei H; Elbahesh E; Tabbara I
Anticancer Res; 2017 Apr; 37(4):1547-1555. PubMed ID: 28373413
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.
Holtan SG; Arora M
Transl Res; 2016 Jan; 167(1):80-7. PubMed ID: 26117290
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
[TBL] [Abstract][Full Text] [Related]
8. [Novel progress on treatment of acute graft-versus-host disease].
Zhou Y; Chen BA; Zhao G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):238-41. PubMed ID: 20137155
[TBL] [Abstract][Full Text] [Related]
9. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.
Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S
Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185
[TBL] [Abstract][Full Text] [Related]
11. Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
Holtan SG; Verneris MR; Schultz KR; Newell LF; Meyers G; He F; DeFor TE; Vercellotti GM; Slungaard A; MacMillan ML; Cooley SA; Blazar BR; Panoskaltsis-Mortari A; Weisdorf DJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1029-36. PubMed ID: 25759146
[TBL] [Abstract][Full Text] [Related]
12. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair.
Zaiss DMW; Gause WC; Osborne LC; Artis D
Immunity; 2015 Feb; 42(2):216-226. PubMed ID: 25692699
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
